{"name":"Novus Therapeutics, Inc","slug":"novus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"Novus Therapeutics, Inc is a biopharmaceutical company focused on developing treatments for respiratory diseases. The company's lead product, Amoxicillin-clavulanate, is currently marketed. Novus continues to explore new therapeutic opportunities to address unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amoxicillin-clavulanate","genericName":"Amoxicillin-clavulanate","slug":"amoxicillin-clavulanate","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Amoxicillin-clavulanate","genericName":"Amoxicillin-clavulanate","slug":"amoxicillin-clavulanate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQdmtFdGhyTTk0VS1SWi1PM2dWSjhYcldfb3VLdGtPZm5UNzBQazhkZ05pRmpuMkdnX1IzTWNrZG9zQkVwX29rT3Q1aFpIbC12T0FXUUs3Tjd3Zzl4OTNUNl9BUkZQNUlCM3hmc1BHSTdiblFXNldQMy0xaWQ2a2pDNDVoMGt5b1ZZRnU1QWY0d2NLMzc4RWdqTEdrelE?oc=5","date":"2025-08-13","type":"pipeline","source":"pharmaphorum","summary":"Xenotransplantation at the brink of breakthrough: A new era in organ transplantation - pharmaphorum","headline":"Xenotransplantation at the brink of breakthrough: A new era in organ transplantation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNaFhLc3BPZFB2M1hpY0NsVGVwZnhtLVdKTGthT0VCUXFad2N1VnhJdnFvUVhzenRrVW9OV3Fmd3d1SXVpYk5aTFdDOGphWFRBWF9GRHJDTWhxelpXdWJadFlqOFlXSjM5bGZXT3ZlRTNRWFpHTk1rVzdCd1NMTDYzSnBVT0xUVEdFYVAwNFZaTmRPeG13MFZUZUlFZGhsdXk1U1UtcHRoWnZ5eXA1TlBzU3RaTGJvR1dhSnZfVjR4TDd3SG1EWXV0NmppbWVvUnd1dEk1ZVZTWXU1WG4yTDNz?oc=5","date":"2024-10-21","type":"pipeline","source":"The Chronicle-Journal","summary":"Alpha Cognition Announces Appointment of VP Finance and Accounting - The Chronicle-Journal","headline":"Alpha Cognition Announces Appointment of VP Finance and Accounting - The Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9pWnhyVzNiNExjTF9tYXBvWjl1eDdsdUdvQzZzUHpURVZ4cmlONk4zUWxZTERkRmZZR0x3RkozZ01ieEhhRVgtQzI4Ym9tVEs2QTZFX1BtWGxfOTFyb1JMQXh3dzFLb1hleVQ2dVFtaVJCQS1WWDFlRXdiRHlNdw?oc=5","date":"2022-09-09","type":"trial","source":"Orange County Business Journal","summary":"Augie’s Quest to Get ALS Treatment to Trial - Orange County Business Journal","headline":"Augie’s Quest to Get ALS Treatment to Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9HYkducmRERmYtMXM0aldXUXpOaVBPR3E4WHpramdVdFNtSGlEZ1gxTl9MblRndGRzUmd2dFdKZDFYNGtmem84S1RCZXJKTjI0bnc?oc=5","date":"2021-01-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Eledon Pharmaceuticals, Inc. (ELDN) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Eledon Pharmaceuticals, Inc. (ELDN) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNUHl2d3RSRDNaMWxBeHVBaW43SzdtajVjS0VrZUVVaG5NVW92dFh0N1VkbHd4WHhDbTE5Tm02TUVNSGNkS1hHZW1hNVhHOTdKUEQ4WVprcFR5bHJOeUhOREpVeUNtX2hJZE9VOEY5LVZjR0FlZHNJOVVEdTQ5V0g2ell3NGUyLVRXMC13YnJUSQ?oc=5","date":"2021-01-04","type":"pipeline","source":"Yahoo Finance","summary":"Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook - Yahoo Finance","headline":"Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTHVldy1JODJzMzBxOHp0bUxySk9MX1BnbExTWVNadjhzcU92YW1WdG5xampDTnhVNlBoVnZJUUNQX2VyRXh0OEZYVVY5eXZjRDA4ams3LTJwelNNQTVFbHd5U1hhTVBCTHo0RUc4WTBHVzVoaVRyWTBMMHAxcUp1LXViN3pUcEVGVGNKTlFRYlRiME1QOGg4bUhkRk1OMlN1SmY1Y0hVNGU?oc=5","date":"2017-07-10","type":"pipeline","source":"PR Newswire","summary":"Novus Therapeutics Announces Change in Management - PR Newswire","headline":"Novus Therapeutics Announces Change in Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQWGJYd29yc0hsaW1SR2xfYkgzTGozLUpKWFdtbkpjclc1Y0RTWE9FTFZ6RHFQU3RPMjRGYmhxc3dPR1dDYWFrT2t2a2ExV0pGX0FJYTBES3JuUE5wRVNHZ0lESGh4V1lkMzdRRFV4Z000ODNkU0hESkFiQ2d4Rkl1eE5jOGJpbkYyMnJKLWJoSlIxQVFxamNjQWJUNDBhQlpyWUo1Sy1hSko3ZnE2Q1ZGRw?oc=5","date":"2017-05-11","type":"deal","source":"PR Newswire","summary":"Otic Pharma Completes Merger with Tokai Pharmaceuticals - PR Newswire","headline":"Otic Pharma Completes Merger with Tokai Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}